FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
41,315,691
Share change
+2,331,839
Total reported value
$1,556,341,973
Put/Call ratio
233%
Price per share
$37.67
Number of holders
143
Value change
+$401,187,467
Number of buys
95
Number of sells
74

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q1 2021

As of 31 Mar 2021, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,315,691 shares. The largest 10 holders included BVF INC/IL, BlackRock Inc., Rock Springs Capital Management LP, Magnetar Financial LLC, VANGUARD GROUP INC, ALPINE ASSOCIATES MANAGEMENT INC., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, GOLDMAN SACHS GROUP INC, and Pentwater Capital Management LP. This page lists 143 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.